Skip to main content

The Front Row lecture series: Darrell Irvine, PhD

Wednesday, November 18, 2026

4:00-6:00 PM PT

Department of Immunology & Microbiology

Share

Add to Calendar:

Controlling the where, when and how long of vaccine delivery

Scientists are designing vaccines that produce stronger, more durable immune responses. In this free Front Row lecture, Scripps Research professor and the Lita Annenberg Hazen Chair Darrell Irvine will explore how controlling where vaccine components travel in the body—and when and for how long they are delivered—could improve vaccine performance. Irvine will highlight two approaches his lab has advanced into clinical testing: saponin/monophosphoryl lipid A nanoparticles (SMNP), a new vaccine adjuvant designed to strengthen immune responses, and “escalating dose immunization,” a dosing strategy that delivers a vaccine gradually over time. Together, these technologies offer new ways to guide vaccine components to lymphoid tissues, where immune responses take shape.

About the Front Row lecture series

Whether you’re a science enthusiast or a lifelong learner, our Front Row lecture series is designed for you. From protein “choreography” to immune system-boosting sugars to regenerative medicines, learn about the trailblazing discoveries at Scripps Research that could transform human health. Tune in virtually along with thousands around the world, or join us in person in La Jolla, California. 

The Front Row experience… science so close, it’s personal.
Learn more at frontrow.scripps.edu.

More to explore
TIME100 Health list features Scripps Research Professor Darrell Irvine
News

TIME100 Health list features Scripps Research Professor Darrell Irvine

Irvine is recognized for his work in empowering the immune system to fight disease, which includes enhancing vaccines against HIV and cancer. 

Two-part vaccine strategy generates a stronger, longer-lasting immune boost against HIV
News

Two-part vaccine strategy generates a stronger, longer-lasting immune boost against HIV

Scripps Research scientists’ new approach combines two immune-activating molecules known as adjuvants.

Scripps Research awarded $6.9 million by NIH to crack the code of lasting HIV vaccine protection
News

Scripps Research awarded $6.9 million by NIH to crack the code of lasting HIV vaccine protection

The funding will support a multidisciplinary collaboration of four Scripps Research scientists to identify more effective vaccines to treat HIV.

How “invisible” vaccine scaffolding boosts HIV immune response
News

How “invisible” vaccine scaffolding boosts HIV immune response

Scripps Research scientists designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus.

Event background

The Front Row lecture series: Ryan Shenvi, PhD

Wednesday, August 19, 2026

4:00 - 6:00 PM PT

Enter curious, leave informed.

Event background

The Front Row lecture series: Giordano Lippi, PhD

Wednesday, September 9, 2026

4:00 - 6:00 PM PT

Enter curious, leave informed.

Event background

The Front Row lecture series: Christian Diercks, PhD

Wednesday, October 14, 2026

4:00 - 6:00 PM PT

Enter curious, leave informed.

Groundbreaking Science.
Life-changing Medicine.